Thelansis

 Thrombocytopenia is defined as the deficiency of platelets (thrombocytes) that increases the risk of bleeding. It occurs when the bone marrow produces insufficient platelets or when an excessive number of platelets are destroyed or accumulated within an enlarged spleen. In this condition, the platelet count of patients drops down to less than 150 x 103 per μL. Typically, platelet counts higher than 50 x 109 per L do not lead to clinical problems unless platelet dysfunction co-exists with the low count; instead, they are picked up on a routine complete blood count. It is classified as Idiopathic Thrombocytopenic Purpura, Thrombotic Thrombocytopenic Purpura, Drug-Induced Thrombocytopenia, and others based on etiology. Immune (Idiopathic) Thrombocytopenic Purpura is an acquired immune-mediated disorder that occurs due to the destruction of premature platelets. It is characterized by minimal bleeding or severe hemorrhage such as mucosal, intracranial, gastrointestinal, and genitourina...

  Thrombocytopenia is defined as the deficiency of platelets (thrombocytes) that increases the risk of bleeding. It occurs when the bone marrow produces insufficient platelets or when an excessive number of platelets are destroyed or accumulated within an enlarged spleen. In this condition, the platelet count of patients drops down to less than 150 x 103 per μL. Typically, platelet counts higher than 50 x 109 per L do not lead to clinical problems unless platelet dysfunction co-exists with the low count; instead, they are picked up on a routine complete blood count. It is classified as Idiopathic Thrombocytopenic Purpura, Thrombotic Thrombocytopenic Purpura, Drug-Induced Thrombocytopenia, and others based on etiology. Immune (Idiopathic) Thrombocytopenic Purpura is an acquired immune-mediated disorder that occurs due to the destruction of premature platelets. It is characterized by minimal bleeding or severe hemorrhage such as mucosal, intracranial, gastrointestinal, and genitourin...

  Thrombocytopenia is defined as the deficiency of platelets (thrombocytes) that increases the risk of bleeding. It occurs when the bone marrow produces insufficient platelets or when an excessive number of platelets are destroyed or accumulated within an enlarged spleen. In this condition, the platelet count of patients drops down to less than 150 x 103 per μL. Typically, platelet counts higher than 50 x 109 per L do not lead to clinical problems unless platelet dysfunction co-exists with the low count; instead, they are picked up on a routine complete blood count. It is classified as Idiopathic Thrombocytopenic Purpura, Thrombotic Thrombocytopenic Purpura, Drug-Induced Thrombocytopenia, and others based on etiology. Immune (Idiopathic) Thrombocytopenic Purpura is an acquired immune-mediated disorder that occurs due to the destruction of premature platelets. It is characterized by minimal bleeding or severe hemorrhage such as mucosal, intracranial, gastrointestinal, and genitourin...